ERN ReCONNET
COVID-19
American College of Rheumatology recommendations
ACR recommendations
The American College of Rheumatology has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
ACR support the COVID-19 Global Rheumatology Alliance, a provider-entered registry that aims to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.
ACR has also developed a COVID-19 Practice and Advocacy Resources web page, where you can find updates on Telehealth, Drug Shortages, Economic and Practice Support, and Insurance Advocacy.
[foogallery id=”8502″]
ACR support the COVID-19 Global Rheumatology Alliance, a provider-entered registry that aims to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.
ACR has also developed a COVID-19 Practice and Advocacy Resources web page, where you can find updates on Telehealth, Drug Shortages, Economic and Practice Support, and Insurance Advocacy.
